Patents by Inventor Gerald D. Cagle

Gerald D. Cagle has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of sustained release antibiotic compositions in ophthalmic surgical procedures
    Patent number: 5631004
    Abstract: An improved method of sterilizing the field of surgery prior to an ophthalmic surgical procedure is described. The invention eliminates the need for painful and potentially traumatic injections of antibiotics by utilizing sustained release compositions which allow the antibiotics contained therein to penetrate deeply into the eye, thereby ensuring a sterile field of surgery during intraocular surgical procedures. The compositions may also be utilized to prevent post-surgical infections.
    Type: Grant
    Filed: September 30, 1993
    Date of Patent: May 20, 1997
    Assignee: Alcon Laboratories, Inc.
    Inventors: Gerald D. Cagle, Tai-Lee Ke, Barry A. Schlech, Ole J. Lorenzetti
  • Combination of tobramycin and fluorometholone for topical ophthalmic use
    Patent number: 5149693
    Abstract: Disclosed are pharmaceutical compositions comprising tobramycin and fluorometholone or fluorometholone acetate for topical ophthalmic delivery and methods of treatment comprising administering said composition when indicated for infection and control of inflammatory response for optimal wound healing and normalization of the eye.
    Type: Grant
    Filed: November 22, 1989
    Date of Patent: September 22, 1992
    Assignee: Alcon Laboratories, Inc.
    Inventors: Gerald D. Cagle, Thomas O. McDonald, Allan L. Rosenthal
  • Combination of tobramycin and dexamethasone for topical ophthalmic use
    Patent number: 5149694
    Abstract: Disclosed are pharmaceutical compositions comprising tobramycin and dexamethasone for topical ophthalmic delivery and a method of treatment comprising administering said composition when indicated for infection and control of inflammatory response for optimal wound healing and normalization of the eye.
    Type: Grant
    Filed: November 22, 1989
    Date of Patent: September 22, 1992
    Assignee: Alcon Laboratories, Inc.
    Inventors: Gerald D. Cagle, Thomas O. McDonald, Allan L. Rosenthal